991 related articles for article (PubMed ID: 1826033)
1. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
2. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. II. High efficacy 5-HT1A agonists attenuate morphine-induced antinociception in mice in a competitive-like manner.
Millan MJ; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):983-92. PubMed ID: 1672380
[TBL] [Abstract][Full Text] [Related]
3. Pharmacology of 5-hydroxytryptamine-1A receptors which inhibit cAMP production in hippocampal and cortical neurons in primary culture.
Dumuis A; Sebben M; Bockaert J
Mol Pharmacol; 1988 Feb; 33(2):178-86. PubMed ID: 2828913
[TBL] [Abstract][Full Text] [Related]
4. Agonist action at 5-HT1C receptors facilitates 5-HT1A receptor-mediated spontaneous tail-flicks in the rat.
Bervoets K; Millan MJ; Colpaert FC
Eur J Pharmacol; 1990 Nov; 191(2):185-95. PubMed ID: 2150818
[TBL] [Abstract][Full Text] [Related]
5. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
6. 5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats.
Millan MJ; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):993-1001. PubMed ID: 1672381
[TBL] [Abstract][Full Text] [Related]
7. A nonclassical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system.
Dumuis A; Bouhelal R; Sebben M; Cory R; Bockaert J
Mol Pharmacol; 1988 Dec; 34(6):880-7. PubMed ID: 2849052
[TBL] [Abstract][Full Text] [Related]
8. Apparent hyperalgesic action of the 5-HT1A agonist, 8-OH-DPAT, in the rat reflects induction of spontaneous tail-flicks.
Millan MJ; Bervoets K; Colpaert FC
Neurosci Lett; 1989 Dec; 107(1-3):227-32. PubMed ID: 2533334
[TBL] [Abstract][Full Text] [Related]
9. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
10. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
Goodwin GM; Green AR
Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
[TBL] [Abstract][Full Text] [Related]
11. Modulation of the discriminative stimulus properties of cocaine by 5-HT1B and 5-HT2C receptors.
Callahan PM; Cunningham KA
J Pharmacol Exp Ther; 1995 Sep; 274(3):1414-24. PubMed ID: 7562516
[TBL] [Abstract][Full Text] [Related]
12. Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.
Gobert A; Lejeune F; Rivet JM; Audinot V; Newman-Tancredi A; Millan MJ
J Pharmacol Exp Ther; 1995 Jun; 273(3):1032-46. PubMed ID: 7791073
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1A and alpha-2 adrenergic receptors mediate the hyperglycemic and hypoinsulinemic effects of 8-hydroxy-2-(di-n-propylamino)tetralin in the conscious rat.
Chaouloff F; Jeanrenaud B
J Pharmacol Exp Ther; 1987 Dec; 243(3):1159-66. PubMed ID: 2826757
[TBL] [Abstract][Full Text] [Related]
14. Evidence that 5-HT2 receptors mediate the pressor effect of 8-OH-DPAT in the spinally pithed rat.
Deckert V; Chaouloff F; Richer C; Elghozi JL
Arch Int Pharmacodyn Ther; 1990; 306():114-29. PubMed ID: 1981665
[TBL] [Abstract][Full Text] [Related]
15. Behavioural profiles of putative 5-hydroxytryptamine receptor agonists and antagonists in developing rats.
Jackson HC; Kitchen I
Neuropharmacology; 1989 Jun; 28(6):635-42. PubMed ID: 2526930
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the discriminative stimulus properties induced by 5-HT1 and 5-HT2 agonists in rats.
Arnt J
Pharmacol Toxicol; 1989 Feb; 64(2):165-72. PubMed ID: 2526950
[TBL] [Abstract][Full Text] [Related]
17. 5-Hydroxytryptamine (5-HT)-induced endothelium-dependent relaxation of pig coronary arteries is mediated by 5-HT receptors similar to the 5-HT1D receptor subtype.
Schoeffter P; Hoyer D
J Pharmacol Exp Ther; 1990 Jan; 252(1):387-95. PubMed ID: 2137176
[TBL] [Abstract][Full Text] [Related]
18. Stimulation of corticosterone secretion by the selective 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in the rat.
Przegaliński E; Budziszewska B; Warchoł-Kania A; Błaszczyńska E
Pharmacol Biochem Behav; 1989 Jun; 33(2):329-34. PubMed ID: 2530590
[TBL] [Abstract][Full Text] [Related]
19. Characterization of 5-hydroxytryptamine receptors in bovine coronary arteries.
Foy RA; Myles JL; Wilkerson RD
J Pharmacol Exp Ther; 1992 May; 261(2):601-6. PubMed ID: 1533667
[TBL] [Abstract][Full Text] [Related]
20. Influence of urapidil and 8-OH-DPAT on brain 5-HT turnover and blood pressure in rats.
Valenta B; Kotai E; Weisz E; Singer EA
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S68-74. PubMed ID: 1702489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]